These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39320512)

  • 1. Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas.
    Joliat GR; Labgaa I; Martin D; Vrochides D; Schäfer M
    Langenbecks Arch Surg; 2024 Sep; 409(1):282. PubMed ID: 39320512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.
    Joliat GR; Gaspar-Figueiredo S; Labgaa I; Vrochides D; Perinel J; Adham M; Demartines N; Schäfer M
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17007-17014. PubMed ID: 37740766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
    Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma.
    Joliat GR; Labgaa I; Gilgien J; Demartines N
    Pancreas; 2021 Jan; 50(1):104-110. PubMed ID: 33370031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of positive histological margins in patients with pancreatic head ductal adenocarcinoma and lymph node involvement: an international multicentric study.
    Joliat GR; Allemann P; Labgaa I; Sulzer J; Vrochides D; Zerbi A; Nappo G; Perinel J; Adham M; Nentwich MF; Izbicki JR; Demartines N; Schäfer M
    HPB (Oxford); 2021 Mar; 23(3):379-386. PubMed ID: 32782224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.
    Li SS; Zhou CY; Liao R; Xiong L; Weng NN; Zhao YQ; Mason C; Gou HF; Yi C; Zhu Q
    Medicine (Baltimore); 2020 Apr; 99(14):e19413. PubMed ID: 32243360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of hemoglobin to red blood cell distribution width ratio in pancreatic ductal adenocarcinoma: a retrospective study.
    Zhou G; Yang L; Lu Y; Lu G
    BMC Gastroenterol; 2024 Aug; 24(1):288. PubMed ID: 39192176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
    Williams H; Jajja MR; Hashmi SS; Maxwell D; Cardona K; Maithel SK; Russell MC; Sarmiento JM; Winer JH; Kooby DA
    HPB (Oxford); 2020 Nov; 22(11):1557-1562. PubMed ID: 32146119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection.
    Dillon DL; Park JY; Mederos MA; Seo YJ; King J; Hines J; Donahue T; Girgis MD
    J Surg Oncol; 2024 Jul; 130(1):72-82. PubMed ID: 38726668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does blood group affect survival following pancreatoduodenectomy for periampullary malignancy?
    Khalil K; Bansal S; Ayaani S; Hodson J; Lam FT; Khan S; Ahmad J; Isaac J; Muiesan P; Mirza D; Dasari B; Marudanayagam R; Sutcliffe RP; Marangoni G; Roberts KJ
    HPB (Oxford); 2018 Sep; 20(9):848-853. PubMed ID: 29705345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance?
    LaFemina J; Chou JF; Gönen M; Rocha FG; Correa-Gallego C; Kingham TP; Fong Y; D'Angelica MI; Jarnagin WR; DeMatteo RP; Allen PJ
    J Gastrointest Surg; 2013 Jun; 17(6):1092-7. PubMed ID: 23588624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
    Estrella JS; Rashid A; Fleming JB; Katz MH; Lee JE; Wolf RA; Varadhachary GR; Pisters PW; Abdalla EK; Vauthey JN; Wang H; Gomez HF; Evans DB; Abbruzzese JL; Wang H
    Cancer; 2012 Jan; 118(1):268-77. PubMed ID: 21735446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    Konishi T; Takano S; Takayashiki T; Suzuki D; Sakai N; Hosokawa I; Mishima T; Nishino H; Suzuki K; Nakada S; Ohtsuka M
    Ann Surg Oncol; 2024 Oct; 31(10):6992-7000. PubMed ID: 38926210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancreaticoduodenectomy.
    Qiu G; Zhang L; Gu Z; Ren H; Du Y; Li Z; Wang C
    Med Sci Monit; 2021 Oct; 27():e931868. PubMed ID: 34599137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.